PHIA Koninklijke Philips N.V.

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

November 24, 2025

  • New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows



Amsterdam, the Netherlands –
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, [1] that transforms how radiologists access and interpret medical images. Designed with a brand-new user interface, the viewer delivers the full clinical power of a desktop workstation through a standard web browser. It combines clinical depth, mobility, and scalability, enabling radiologists to work smarter, faster, and more collaboratively – while giving back time to clinical teams and reducing IT complexity across the enterprise.



A complete diagnostic experience – anytime, anywhere

In today’s healthcare environment, time, accuracy, and accessibility are critical. The viewer helps address one of healthcare’s most persistent challenges, lost clinical time caused by slow performance and the complexity of remote reading. It delivers high-performance server-side rendering, workflow automation, and a full suite of advanced clinical tools – all accessed securely through a web browser, with no local installation required.  

“We were among the first to test the new Philips web-based diagnostic viewer, and the difference is clear. It loads studies quickly and runs smoothly, even with large datasets. The new interface is intuitive and lets us focus entirely on the images, a real step forward in performance and usability,” said Pieter Hoste, Chief Radiologist and Head of Medical Imaging, AZ West Hospital, Belgium.

Processing between the client and server is optimized to ensure seamless performance, even with large, complex datasets such as digital breast tomosynthesis or cardiac CT. This delivers consistent, high-quality image interpretation – whether radiologists are working on-site, across the enterprise, or remotely – while simplifying IT deployment and management. 

The web-based viewer interfaces with connected AI tools to bring together all relevant patient information in one place, supporting faster, more informed diagnoses. Natively connected to the interactive reporting module, it manages reporting in the PACS workflow, eliminating the need for separate dictation or reporting systems and enabling radiologists to review images and generate comprehensive reports without leaving their reading application.

The new user interface provides access to a comprehensive suite of advanced clinical applications and accelerates interpretation by aligning images across modalities and time points, all seamlessly integrated with the interactive reporting application. Combined with the , which embeds deeper analysis results directly into the reporting workflow, clinicians benefit from greater efficiency and productivity. 

Cloud-enabled deployment for scalable, connected radiology

The viewer is built for cloud deployment through , powered by Amazon Web Services (AWS), with an on-premises option for added flexibility. This approach preserves current infrastructure investments and enables a seamless transition to the cloud at each organization’s pace.

“Health systems are under intense pressure to do more with less. The web diagnostic viewer is a milestone in our journey toward cloud-enabled, AI-integrated diagnostic imaging. It brings the power of advanced visualization, collaboration, and intelligence to any browser, helping radiologists stay connected and productive wherever care happens while streamlining IT operations,” said Madhuri Sebastian, Business Leader Imaging Informatics at Philips.

The web-based diagnostic viewer on Philips HealthSuite cloud is offered as a SaaS (Software as a Service) solution, with built-in security, and effortless scalability across multiple sites. It ensures consistent performance and collaboration for teams working on-site, remotely, or across borders and is currently available in the USA, with expansion to additional regions planned for 2026.

Philips at RSNA

At , Philips will highlight its new informatics solutions and AI-driven imaging ecosystem in development, featuring generative AI to automate workflow tasks like display protocol normalization and patient summaries, and Agentic AI [2] for anatomy-aware automation that streamlines study prioritization and workflow orchestration.

[1] The Philips web diagnostic viewer is available today to select customers, with broader market availability to follow. Future availability cannot be ensured.

[2] Work in progress, not available for global distribution. Future availability cannot be ensured.

For further information, please contact:

Anna Hogrebe

Philips Global External Relations

Tel.:

E-mail:

 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachment



EN
24/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch